Stock Ideas 
News Letter Reviews Rob Fannon's Phase 1 Investor Reviews
News Letter Reviews Rob Fannon's Phase 1 Investor Reviews 
Market Watch
|
By Charles Delvalle Is there any doubt that there’s a speculative bubble in Chinese companies? With that in mind, reader John S asked: Alibaba, China's second-most popular Internet search engine behind Baidu (BIDU), is going public today on the Hong Kong stock exchange. The IPO is priced at $13.50, but shares are expected to hit the tape at almost twice that price. Charles, could this be true? Regards, John |
|
| More... |
Most Popular
Login Form
| Rob Fannon's Phase 1 Investor Reviews |
| Tuesday, 29 July 2008 | |||||||||
|
The U.S. government is falling over itself right now in an effort to "save the economy." But the irony is, while the Feds focus on the current crisis in housing and banking...they have created an opportunity for ordinary Americans to make extraordinary gains in another, completely unrelated sector of the economy. What kind of gains am I talking about? Well, take Novavax (NVAX) for instance, a company headquartered in Rockville, Maryland. Few people have heard of NVAX... and even fewer know why this stock soared 1,022% in late 2006. Nothing out of the ordinary happened to the company. There were no unusual deals inked and no special earnings announcements. They barely got a mention in The Wall Street Journal or The New York Times... Yet NVAX shareholders were able to turn every $10,000 invested into a whopping $112,200. What is The Classified Gov't Document (filed at 12501 Washington Ave)The same thing happened with Cerus (CERS), a $166M company based in California.Again... nothing remarkable or unusual happened to this company. But in 2004, it shot up 656%... Why are these obscure stocks no one's heard of posting gains of 523%... 1,022%... even 4,046%... in as little as six months, largely thanks to the U.S. Government? The answer lies in a classified document, compiled by a Federal agency in Washington D.C. Just weeks ago, some of the information – a 1-page list of stocks – was quietly declassified while no one was paying attention... And now, over the next six months, there's an opportunity for some investors to make a heck of a lot of money. Here's what I recommend you do:
Joining us on these calls will be the industry insiders, company executives and independent researchers Rob interviews and meets with while investigating each situation. These calls are complimentary benefits of your membership. Of course, if you can't participate, we'll provide a complete transcript for your review. Phase 1 normally costs $5,000 a year. In the past, we have offered discounts. But today, you can take a no-risk trial look at Phase 1 with a purchase of just $900. There has never been a cheaper way to try this research. The full details are explained on the attached order form. For more information and to get started, click here. Good investing, George Rayburn Publisher, Stansberry & Associates
|
|||||||||
Reviews (1)
| < Prev | Next > |
|---|
